VivoSim Labs, Inc. (VIVS)

VivoSim Labs Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	11.31	2.9	15.3	28.68	37.36
Short-Term Investments	-	-	0.71	-	-
Cash & Short-Term Investments	11.31	2.9	16.01	28.68	37.36
Cash Growth	289.94%	-81.88%	-44.18%	-23.25%	36.58%
Receivables	0.03	0.03	0.15	-	-
Inventory	-	0.3	-	-	-
Prepaid Expenses	0.79	0.7	0.82	0.86	1.03
Other Current Assets	-	0	0.07	-	-
Total Current Assets	12.13	3.94	17.05	29.53	38.4
Property, Plant & Equipment	1.29	1.97	2.61	2.82	0.38
Other Intangible Assets	-	0.01	0.01	0.09	0.11
Other Long-Term Assets	1.23	0.44	0.65	0.85	1.03
Total Assets	14.65	6.35	20.31	33.3	39.92
Accounts Payable	1.64	0.63	0.33	0.42	0.28
Accrued Expenses	1.35	0.73	2.85	0.49	0.44
Current Portion of Leases	0.52	0.51	0.49	0.48	-
Other Current Liabilities	0.22	-	-	-	-
Total Current Liabilities	3.74	1.86	3.67	1.38	0.72
Long-Term Leases	0.42	0.89	1.31	1.7	-
Total Liabilities	4.16	2.75	4.98	3.09	0.72
Common Stock	0	0.01	0.01	0.01	0.01
Additional Paid-In Capital	352.65	343.26	340.32	337.94	335.48
Retained Earnings	-342.16	-339.67	-325	-307.74	-296.29
Treasury Stock	-0	-0	-0	-0	-0
Comprehensive Income & Other	-	-	0	-	-
Shareholders' Equity	10.49	3.6	15.33	30.21	39.2
Total Liabilities & Equity	14.65	6.35	20.31	33.3	39.92
Total Debt	0.94	1.39	1.81	2.18	-
Net Cash (Debt)	10.37	1.51	14.2	26.49	37.36
Net Cash Growth	588.12%	-89.39%	-46.39%	-29.10%	36.58%
Net Cash Per Share	7.09	1.98	19.56	36.53	64.96
Filing Date Shares Outstanding	2.6	1.2	0.73	0.73	0.72
Total Common Shares Outstanding	1.9	0.84	0.73	0.73	0.72
Working Capital	8.39	2.08	13.38	28.15	37.68
Book Value Per Share	5.53	4.29	21.10	41.62	54.25
Tangible Book Value	10.49	3.59	15.32	30.12	39.09
Tangible Book Value Per Share	5.53	4.28	21.08	41.49	54.10
Machinery	-	1.68	1.64	1.21	0.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.